Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Updated the page to v3.2.0 and added a government-operational status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T17:30:22.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Page version updated from v3.0.2 to v3.1.0 with an added contact-like string (+86-571-87235147); no changes to core content, pricing, or availability inferred.
    Difference
    0.1%
    Check dated 2025-09-28T10:43:19.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Core change: Revision updated to v3.0.2 (replacing v3.0.1). Minor UI change: the 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-14T00:33:55.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-06T21:29:12.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has added significant information regarding drug therapies, specifically for Toripalimab and Surufatinib, along with related topics on colorectal cancer. Additionally, the facility name and location have been updated.
    Difference
    2%
    Check dated 2025-08-30T16:01:39.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-16T12:53:01.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.